Visceral technetium-99 m-labeled pyrophosphate uptake in patients with wild-type transthyretin cardiac amyloidosis

IF 2.4 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Koji Takahashi, Shuhei Yamamoto, Daisuke Sasaki, Takaaki Iwamura, Yoshiyasu Hiratsuka, Sohei Kitazawa, Nobuhisa Yamamura, Mitsuharu Ueda, Yushi Utsunomiya, Hiroe Morioka, Shigeki Uemura, Tomoki Sakaue, Katsuji Inoue
{"title":"Visceral technetium-99 m-labeled pyrophosphate uptake in patients with wild-type transthyretin cardiac amyloidosis","authors":"Koji Takahashi,&nbsp;Shuhei Yamamoto,&nbsp;Daisuke Sasaki,&nbsp;Takaaki Iwamura,&nbsp;Yoshiyasu Hiratsuka,&nbsp;Sohei Kitazawa,&nbsp;Nobuhisa Yamamura,&nbsp;Mitsuharu Ueda,&nbsp;Yushi Utsunomiya,&nbsp;Hiroe Morioka,&nbsp;Shigeki Uemura,&nbsp;Tomoki Sakaue,&nbsp;Katsuji Inoue","doi":"10.1007/s12149-026-02174-4","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Technetium-99 m-labeled pyrophosphate (Tc-99 m-PYP) scintigraphy can image tracer uptake in the myocardium, subcutaneous fat, and skeletal muscles of patients with wild-type amyloid transthyretin (ATTRwt) cardiac amyloidosis (CA), which indicates ATTR deposition. However, there are few reports of visceral Tc-99 m-PYP uptake in patients with ATTRwt-CA. This study was conducted to determine whether Tc-99 m-PYP scintigraphy can image ATTR deposition in the viscera, particularly the liver, spleen, and gastrointestinal tract.</p><h3>Methods</h3><p>Chest- and abdomen-centered Tc-99 m-PYP scintigraphy with single-photon emission computed tomography-computed tomography fusion images were acquired 2 h after patients with clinically suspected CA were intravenously injected with 20 mCi of the tracer. The participants were divided into two groups: ATTR-CA and non-ATTR-CA groups. Semi-quantitative visual grade of hepatic tracer uptake and mean standardized uptake values in the liver (SUV<sub>mean</sub>-L) were investigated. The presence or absence of tracer uptake in the spleen and alimentary tract (stomach, small intestine, and colon, excluding the rectum and anus) was also investigated.</p><h3>Results</h3><p>Of 209 participants (median age, 85 years; range, 79–90 years; 56.5% male), 72 patients, all of whom had ATTRwt-CA, were assigned to the ATTR-CA group, whereas 137 were assigned to the non-ATTR-CA group. Semi-quantitative visual grade of hepatic tracer uptake, SUV<sub>mean</sub>-L, and the rate of splenic tracer uptake did not vary between both groups (<i>p</i> = 0.100, <i>p</i> = 0.904, and <i>p</i> = 0.356, respectively). However, the ATTR-CA group showed a higher rate of tracer uptake in the alimentary tract than the non-ATTR-CA group (<i>p</i> &lt; 0.001). Within the digestive tract, the tracer uptake rates in the small intestine and colon were significantly higher in the ATTR-CA group than in the non-ATTR-CA group (<i>p</i> &lt; 0.001 and <i>p</i> &lt; 0.001, respectively); however, no significant difference was observed in gastric accumulation between the two groups (<i>p</i> = 0.305).</p><h3>Conclusions</h3><p>Tc-99 m-PYP scintigraphy may image ATTR deposition in the small intestine and colon of patients with ATTRwt-CA. In contrast, Tc-99 m-PYP uptake likely reflects blood pool activity rather than ATTR deposition in the liver, spleen, and stomach.</p></div>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":"40 6","pages":"707 - 722"},"PeriodicalIF":2.4000,"publicationDate":"2026-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Nuclear Medicine","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12149-026-02174-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

Technetium-99 m-labeled pyrophosphate (Tc-99 m-PYP) scintigraphy can image tracer uptake in the myocardium, subcutaneous fat, and skeletal muscles of patients with wild-type amyloid transthyretin (ATTRwt) cardiac amyloidosis (CA), which indicates ATTR deposition. However, there are few reports of visceral Tc-99 m-PYP uptake in patients with ATTRwt-CA. This study was conducted to determine whether Tc-99 m-PYP scintigraphy can image ATTR deposition in the viscera, particularly the liver, spleen, and gastrointestinal tract.

Methods

Chest- and abdomen-centered Tc-99 m-PYP scintigraphy with single-photon emission computed tomography-computed tomography fusion images were acquired 2 h after patients with clinically suspected CA were intravenously injected with 20 mCi of the tracer. The participants were divided into two groups: ATTR-CA and non-ATTR-CA groups. Semi-quantitative visual grade of hepatic tracer uptake and mean standardized uptake values in the liver (SUVmean-L) were investigated. The presence or absence of tracer uptake in the spleen and alimentary tract (stomach, small intestine, and colon, excluding the rectum and anus) was also investigated.

Results

Of 209 participants (median age, 85 years; range, 79–90 years; 56.5% male), 72 patients, all of whom had ATTRwt-CA, were assigned to the ATTR-CA group, whereas 137 were assigned to the non-ATTR-CA group. Semi-quantitative visual grade of hepatic tracer uptake, SUVmean-L, and the rate of splenic tracer uptake did not vary between both groups (p = 0.100, p = 0.904, and p = 0.356, respectively). However, the ATTR-CA group showed a higher rate of tracer uptake in the alimentary tract than the non-ATTR-CA group (p < 0.001). Within the digestive tract, the tracer uptake rates in the small intestine and colon were significantly higher in the ATTR-CA group than in the non-ATTR-CA group (p < 0.001 and p < 0.001, respectively); however, no significant difference was observed in gastric accumulation between the two groups (p = 0.305).

Conclusions

Tc-99 m-PYP scintigraphy may image ATTR deposition in the small intestine and colon of patients with ATTRwt-CA. In contrast, Tc-99 m-PYP uptake likely reflects blood pool activity rather than ATTR deposition in the liver, spleen, and stomach.

Abstract Image

野生型转甲状腺素型心脏淀粉样变性患者内脏锝-99 m标记焦磷酸摄取。
目的采用Tc-99 m-PYP显像技术对野生型甲状腺转淀粉样蛋白(attwt)型心脏淀粉样变性(CA)患者心肌、皮下脂肪和骨骼肌的示踪剂摄取情况进行成像,提示ATTR沉积。然而,attrt - ca患者内脏tc - 99m - pyp摄取的报道很少。本研究旨在确定Tc-99 m-PYP闪烁显像是否可以成像内脏,特别是肝脏、脾脏和胃肠道中的ATTR沉积。方法临床疑似CA患者静脉注射20 mCi示踪剂2 h后,以腹部和腹部为中心的Tc-99 m-PYP闪烁成像与单光子发射计算机断层扫描融合成像。参与者被分为两组:atr - ca组和非atr - ca组。研究了肝脏示踪剂摄取的半定量视觉分级和肝脏平均标准化摄取值(SUVmean-L)。还研究了脾脏和消化道(胃、小肠和结肠,不包括直肠和肛门)中示踪剂摄取的存在或缺失。在209名参与者中(中位年龄85岁,范围79-90岁,56.5%为男性),72名患有attrt - ca的患者被分配到attrt - ca组,而137名患者被分配到非attrt - ca组。肝示踪剂摄取的半定量视觉分级、SUVmean-L和脾示踪剂摄取率在两组之间无差异(p = 0.100、p = 0.904和p = 0.356)。然而,与非atr - ca组相比,atr - ca组在消化道中显示出更高的示踪剂摄取率(p < 0.001)。在消化道内,atr - ca组小肠和结肠的示踪剂摄取率显著高于非atr - ca组(p <; 0.001和p <; 0.001);然而,两组胃积液无显著性差异(p = 0.305)。结论stc - 99m - pyp显像可显示ATTR - ca患者小肠和结肠内的ATTR沉积。相比之下,Tc-99 m-PYP摄取可能反映的是血池活动,而不是肝、脾和胃中的ATTR沉积。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annals of Nuclear Medicine
Annals of Nuclear Medicine 医学-核医学
CiteScore
4.90
自引率
7.70%
发文量
111
审稿时长
4-8 weeks
期刊介绍: Annals of Nuclear Medicine is an official journal of the Japanese Society of Nuclear Medicine. It develops the appropriate application of radioactive substances and stable nuclides in the field of medicine. The journal promotes the exchange of ideas and information and research in nuclear medicine and includes the medical application of radionuclides and related subjects. It presents original articles, short communications, reviews and letters to the editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书